arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 2005.01765stat.ME

使用弱遗传因子进行顺式孟德尔随机化中的条件推断

Conditional inference in cis-Mendelian randomization using weak genetic factors

Ashish Patel, Dipender Gill, Paul J. Newcombe, Stephen Burgess

AI总结:

本文提出了一种cis-MR推断方法,利用因子分析降低遗传变异维度并作为工具变量,通过两种条件检验方法解决弱效应下的尺度扭曲问题,为降胆固醇药物靶点验证提供了遗传证据。

摘要:

孟德尔随机化是一种广泛使用的方法,通过将遗传变异作为工具变量来估计暴露对结局的无混杂效应。使用来自单一基因区域变异的孟德尔随机化分析(cis-MR)因能为药物靶点验证提供支持性证据且经济高效而受到欢迎。本文提出了cis-MR推断方法,利用许多相关变异的解释力,即使在那些变异对暴露仅有弱效应的情况下也能进行有效推断。具体而言,我们利用单基因区域中遗传相关性的高度结构化特性,通过因子分析降低遗传变异的维度。然后将这些遗传因子作为工具变量,构建感兴趣因果效应的检验。由于这些因子通常与暴露仅有弱相关性,标准t检验的尺度扭曲可能很严重。因此,我们考虑了两种基于条件检验的方法。首先,我们扩展了常用识别稳健检验的结果,以考虑使用估计因子作为工具变量。其次,我们提出了一种检验,能够根据相关性适当调整遗传因子的第一阶段筛选。我们的实证结果提供了遗传证据,以验证旨在预防冠心病的降胆固醇药物靶点。

英文摘要:

Mendelian randomization is a widely-used method to estimate the unconfounded effect of an exposure on an outcome by using genetic variants as instrumental variables. Mendelian randomization analyses which use variants from a single genetic region (cis-MR) have gained popularity for being an economical way to provide supporting evidence for drug target validation. This paper proposes methods for cis-MR inference which use the explanatory power of many correlated variants to make valid inferences even in situations where those variants only have weak effects on the exposure. In particular, we exploit the highly structured nature of genetic correlations in single gene regions to reduce the dimension of genetic variants using factor analysis. These genetic factors are then used as instrumental variables to construct tests for the causal effect of interest. Since these factors may often be weakly associated with the exposure, size distortions of standard t-tests can be severe. Therefore, we consider two approaches based on conditional testing. First, we extend results of commonly-used identification-robust tests to account for the use of estimated factors as instruments. Secondly, we propose a test which appropriately adjusts for first-stage screening of genetic factors based on their relevance. Our empirical results provide genetic evidence to validate cholesterol-lowering drug targets aimed at preventing coronary heart disease.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑